Smoking Cessation Report: Forecasts 2009-2024

NEW YORK--(Business Wire)--
Reportlinker.com announces that a new market research report is available in its
catalogue.

Smoking Cessation Report, 2009-2024

http://www.reportlinker.com/p0109863/Smoking-Cessation-Report-2009-2024.html

Smoking is the leading cause of preventable death in the world. The effects of
smoking represent a global pandemic of enormous proportions. Currently-marketed
smoking cessation aids typically lack high levels of efficacy in practice and
are associated with marked side-effects. There are clear market opportunities
for novel, more-efficacious and safer smoking cessation agents, in both
prescription and OTC forms.

In 2008, total sales of prescription and OTC smoking cessation products amounted
to over $3bn worldwide. Smoking Cessation, 2009-2024 forecasts how this market
will grow and develop from 2009 to 2024. The author of this report predicts that
launches of nicotine vaccines from 2011 onwards will alleviate some of the
currently-unmet needs in smoking cessation. Which nicotine vaccine will be first
to market? Smoking Cessation, 2009-2024 answers that question and many others,
providing expert-opinion and analyses on the development of smoking cessation
products of many types, dealing with both pipeline and marketing developments in
the sector. During the next 15 years, overall growth in the world smoking
cessation market will be increasingly contributed by the BRIC (Brazil, Russia,
India and China) group of countries. Nearly half of the world`s smokers live in
BRIC areas, yet those country markets yielded low per capita smoking cessation
revenues in 2008. Smoking Cessation, 2009-2024 analyses the BRIC smoking
cessation markets and their prospects for future growth, revealing how their
market shares will increase from 2009 to 2024. This report also analyses the
current-leading markets in North America, Europe and Asia in detail. Smoking
Cessation, 2009-2024 is a comprehensive analysis of the world smoking cessation
market, compiled using a wealth of research tools - including interviews with
key opinion-leaders, examination of company reports, press-releases and filings,
use of commercial databases and analyses of unmet needs and market
opportunities.

Highlights include:

• Forecasts for the world smoking cessation market, leading therapy types,
brands and individual country markets.

• Detailed examination and market forecasts for the individual country smoking
cessation markets in the US, Canada, Brazil, the UK, France, Germany, Sweden,
Russia, Japan, China and India.

• Examination of strengths, weakness, opportunities and threats (SWOT) facing
major stakeholders in the industry.

• In-depth analysis of the pharmacological pipeline for new smoking cessation
products.

Why you should buy this report:

• To receive a comprehensive analysis of the prospects for smoking cessation
therapies from 2009-2024, including predicted revenues, growth rates and other
key metrics.

• To discover the fate of Pfizer`s Chantix/Champix, in light of recent
safety-concerns.

• To identify key pipeline developments and up-and-coming products.

• To discover the forces, restraints, competition and opportunities influencing
each of the separate areas of the smoking cessation market, including nicotine
replacement therapies, Pfizer`s Chantix/Champix and bupropion drugs.

• To find out where the market is heading - both technologically and
commercially - from the present onwards. The majority of smokers worldwide do
not have full access to smoking cessation therapies. Smoking prevalence is
increasing overall, with increases mainly contributed by developing countries.
Adverse health effects and the high economic costs associated with tobacco
smoking are encouraging increasingly-stringent smoking legislation and
encouraging governmental spending on anti-smoking aids. From 2009 to 2024, the
continuing introduction and implementation of tobacco-control policies will
accelerate, further encouraging people to stop smoking, in turn increasing the
use of smoking cessation products.

This report demonstrates how the smoking cessation market will expand worldwide
as a result. Smoking Cessation, 2009-2024 shows that new smoking cessation drugs
will enjoy commercial success only if these are clearly tolerable and
more-effective in practice, easily accessible, backed by innovative marketing
campaigns and delivered in combination with behavioural support programmes.
Smoking cessation drugs with these characteristics will overcome regulatory
hurdles and achieve adequate reimbursement from cost-conscious healthcare
providers.

This report is essential reading for everybody involved in the smoking cessation
market, revealing prospects for both existing competitors and potential market
entrants, from the present onwards.

Table of Contents

1 Executive Summary

2 Introduction to Smoking Cessation

2.1 Tobacco

2.1.1 Types of Tobacco Consumption

2.1.2 Tobacco Use is a Global Pandemic

2.2 Nicotine Addiction

2.3 Smoking Cessation

2.3.1 Why is it Difficult to Stop Smoking?

2.3.2 Methods for Smoking Cessation

2.3.3 Pharmacological Smoking Cessation Products

2.4 Nicotine Replacement Therapy (NRT)

2.4.1 Nicorette NRT (Johnson & Johnson/Takeda)

2.4.2 Nicabate/NicoDerm/Nicorette/NiQuitin NRT Brands (GSK)

2.4.3 Novartis NRT Brands

2.4.4 Other NRT Manufacturers

2.5 Bupropion

2.5.1 Zyban (GSK/Biovail)

2.5.2 Generic Bupropion Drugs

2.6 Chantix/Champix (varenicline, Pfizer)

2.7 Off-Label Drug Prescribing for Smoking Cessation

3 The Global Smoking Cessation Market

3.1 The Global Smoking Cessation Market, 2007-2008

3.1.1 Smoking Cessation Market Value, 2007-2008

3.1.2 Leading Smoking Cessation Product Types, 2007-2008

3.1.3 Leading Smoking Cessation Brands, 2007

3.1.4 Leading Manufacturers of Smoking Cessation Products, 2007

3.2 Global Smoking Cessation Market Forecasts, 2009-2024

3.2.1 Growth in the Smoking Cessation Market, 2009-2024

3.2.2 Emerging Markets and the Fate of Chantix: Smoking Cessation Market
Forecast, 2009-2014

3.2.3 What are the Prospects for the Smoking Cessation Market during 2014-2019?

3.2.4 During 2019-2024 the Smoking Cessation Market Growth Will Accelerate

3.2.5 Smoking Cessation Product Type Sales Forecast, 2009-2024

3.2.6 Nicotine Replacement Therapies Sales Forecast, 2009-2024

3.2.7 Chantix/Champix Sales Forecast, 2009-2024

3.2.8 Bupropion Smoking Cessation Drugs Sales Forecast, 2009-2024

4 Leading Eight Smoking Cessation Country Markets

4.1 Eight Smoking Cessation Markets Had 74% of 2007 World Sales

4.2 Leading Eight Smoking Cessation Country Markets Forecast, 2009-2024

4.3 The US Smoking Cessation Market

4.3.1 Smoking Prevalence Declining in US

4.3.2 Availability and Reimbursement of Smoking Cessation Aids in the US

4.3.3 US Smoking Cessation Market Revenue, 2007-2008

4.3.4 Leading US Smoking Cessation Product Types, 2007-2008

4.3.5 Is there Scope for US Smoking Cessation Market Expansion?

4.3.6 US Smoking Cessation Market Forecast, 2009-2024

4.3.7 US Nicotine Replacement Therapies Sales Forecast, 2009-2024

4.3.8 Chantix (US) Sales Forecast, 2009-2024

4.4 The Canadian Smoking Cessation Market

4.4.1 Current Smoking Prevalence in Canada

4.4.2 Availability and Reimbursement of Smoking Cessation Products in Canada

4.4.3 Canadian Smoking Cessation Market Revenues and Market Shares, 2007

4.4.4 Factors Affecting the Canadian Smoking Cessation Market

4.4.5 Canadian Smoking Cessation Market Forecast, 2009-2024

4.5 The UK Smoking Cessation Market

4.5.1 Tobacco Use in the UK

4.5.2 The UK Pioneers Smoking Cessation Reimbursement and General Sales OTC
Retailing of NRT

4.5.3 The UK is Europe`s Largest Smoking Cessation Market

4.5.4 UK Government Anti-Smoking Legislation Lifts Market

4.5.5 UK Smoking Cessation Market Forecast, 2009-2024

4.6 The French Smoking Cessation Market

4.6.1 French Smoking Prevalence

4.6.2 The French Smoking Cessation Market, 2007-2008

4.6.3 Leading Product Types in the French Smoking Cessation Market, 2007

4.6.4 French Government`s Provision of Smoking Cessation Aid Better than in Many
Other European Countries

4.6.5 French Smoking Cessation Market Forecast, 2009-2024

4.7 The Swedish Smoking Cessation Market

4.7.1 Snus in Sweden Increasing in Prevalence

4.7.2 The Swedish Smoking Cessation Market, 2007-2008

4.7.3 Leading Product Types in the Swedish Smoking Cessation Market, 2007

4.7.4 Swedish Smoking Cessation Market Forecast, 2009-2024

4.8 The German Smoking Cessation Market

4.8.1 The German Smoking Cessation Market, 2007-2008

4.8.2 Leading Product Types in the German Smoking Cessation Market, 2007

4.8.3 Factors Holding Back the German Smoking Cessation Market

4.8.4 German Smoking Cessation Market Forecast, 2009-2024

4.9 The Australian Smoking Cessation Market

4.9.1 The Australian Smoking Cessation Market, 2007-2008

4.9.2 Leading Australian Smoking Cessation Product Types, 2007

4.9.3 Australian Smoking Cessation Market Forecast, 2009-2024

4.10 The Japanese Smoking Cessation Market

4.10.1 Japan has an Undeveloped Smoking Cessation Market

4.10.2 The Japanese Smoking Cessation Market, 2007-2008

4.10.3 Japanese Smoking Cessation Market Forecast, 2009-2024

5 BRIC Smoking Cessation Markets

5.1 Greatest Market Growth Predicted in BRIC

5.2 The Brazilian Smoking Cessation Market

5.2.1 Brazilian Smoking Prevalence

5.2.2 The Brazilian Government has Set Smoking Cessation as a Health Priority

5.2.3 The Brazilian Smoking Cessation Market, 2007

5.2.4 Brazilian Smoking Cessation Market Forecast, 2009-2024

5.3 The Russian Smoking Cessation Market

5.3.1 High Smoking Prevalence in Russia

5.3.2 The Russian Smoking Cessation Market, 2007-2008

5.3.3 Russia Signed the Framework Convention on Tobacco Control in 2008

5.3.4 Russian Smoking Cessation Market Forecast, 2009-2024

5.4 The Indian Smoking Cessation Market

5.4.1 Tobacco in India is Both Smoked and Chewed

5.4.2 The Indian Smoking Cessation Market, 2007-2008

5.4.3 Indian Smoking Cessation Market Still in its Infancy

5.4.4 Prospects for Growth of the Indian Smoking Cessation Market

5.4.5 Indian Smoking Cessation Market Forecast, 2009-2024

5.5 The Chinese Smoking Cessation Market

5.5.1 More than 5 Billion Cigarettes are Smoked in China Every Day

5.5.2 The Chinese Smoking Cessation Market, 2007-2008

5.5.3 The Chinese Smoking Cessation Market is Undeveloped

5.5.4 Smoking Cessation Market Prospects in China and Hong Kong

5.5.5 Chinese Smoking Cessation Market Forecast, 2009-2024

6 Issues Affecting the Smoking Cessation Market

6.1 SWOT Analysis for the Smoking Cessation Market

6.2 Strengths of the Smoking Cessation Industry

6.2.1 Innovation in Smoking Cessation Therapies

6.2.2 Innovative Marketing Techniques

6.2.3 Manufacturers are Providing Support Plans in Combination with
Pharmacotherapy

6.2.4 OTC-Switching

6.3 Weaknesses of the Smoking Cessation Industry

6.3.1 Drugs Do Not Replace the Tactile and Oral Sensations Obtained from Smoking

6.3.2 Currently-Marketed Smoking Cessation Therapies Have High Relapse Rate

6.4 Opportunities for the Smoking Cessation Market

6.4.1 Smoking is Prevalent Worldwide and Slowly Increasing

6.4.2 Countries with Untapped Smoking Cessation Market Potential

6.4.3 Growth of Emerging-Economy Smoking Cessation Markets

6.4.4 Health Effects of Tobacco

6.4.5 Economic Impact of Tobacco

6.4.6 Framework Convention on Tobacco Control (FCTC)

6.4.7 Government Smoking Cessation Programmes

6.4.8 Increasing Tobacco Taxes

6.4.9 Smoking Bans

6.4.10 Warning Information on Tobacco Products

6.4.11 Bans on Tobacco Advertising, Promotion and Sponsorship

6.5 Threats to the Smoking Cessation Industry

6.5.1 Concern over Side-Effects of Smoking Cessation Drugs

6.5.1.1 Champix/Chantix Showed Potential, but then Hit by Safety Concerns

6.5.1.2 Side-Effect Concerns for NRT and Bupropion

6.5.1.3 The Result of Side-Effect Concerns

6.5.2 Lack of Reimbursement for Smoking Cessation Therapies

6.5.3 Traditional Smokeless Tobacco

6.5.3.1 Snus and Gutkha

6.5.3.2 A Possible Impact of Greater Smokeless Tobacco Prevalence

6.5.4 The E-Cigarette

6.5.4.1 What are E-Cigarettes?

6.5.4.2 The E-Cigarette Market

6.5.4.3 E-Cigarettes Will Revolutionise the Face of Tobacco Smoking and Could
Pose a Threat to the Smoking Cessation Market

6.5.4.4 Will E-Cigarettes Compete with Smoking Cessation Therapies?

7 The Smoking Cessation Pipeline

7.1 Novel Vaccines Will Target Nicotine Addiction

7.1.1 NicVAX (Nabi Biopharmaceuticals)

7.1.2 NIC002 (Cytos Biotechnology/Novartis)

7.1.3 TA-NIC (Celtic Pharma)

7.1.4 Niccine (Independent Pharmaceutica)

7.2 Expert Opinion on Nicotine Vaccines from Dr Raafat Fahim, President and
Chief Executive Officer, Nabi Biopharmaceuticals

7.2.1 Vaccines in the Pipeline for Nicotine Addiction

7.2.2 NicVAX Nicotine Vaccine

7.2.3 Other Nicotine Vaccines

7.3 Monoamine Oxidase Inhibitors

7.3.1 EVT 302 (Evotec)

7.3.2 Selegiline (National Institute on Drug Abuse [NIDA])

7.4 Glycine Antagonists

7.5 Opiate Antagonists and Agonists

7.6 Dopamine D3 Antagonists

7.7 Nicotinic Ligands

7.8 Dopamine Uptake Inhibitors

7.9 Cannabinoid Receptor 1 Antagonists

8 Conclusions

8.1 Smoking is a Global Pandemic of Enormous Proportions

8.2 Smoking Cessation

8.3 The Smoking Cessation Market in 2008

8.4 World Smoking Cessation Market, 2009-2024

8.5 Leading Eight Smoking Cessation Markets and BRIC

List of Tables

Table 2.1 Nicotine Replacement Therapy Types

Table 2.2 Nicorette NRT Brands (Johnson & Johnson/Takeda)

Table 2.3 Nicabate/NicoDerm/Nicorette/NiQuitin NRT Brands (GSK)

Table 2.4 Novartis NRT Brands

Table 2.5 Other NRT Brands

Table 2.6 Key Drugs Prescribed Off-Label for Smoking Cessation

Table 3.1 World Smoking Cessation Market Sales, 2007-2008

Table 3.2 Leading Smoking Cessation Product Types, 2007-2008

Table 3.3 Leading Smoking Cessation Brands, 2007

Table 3.4 Leading Manufacturers of Smoking Cessation Products, 2007

Table 3.5 World Smoking Cessation Market Forecast, 2009-2014

Table 3.6 World Smoking Cessation Market Forecast, 2015-2024

Table 3.7 Smoking Cessation Product Type Sales Forecast, 2009-2014

Table 3.8 Smoking Cessation Product Type Sales Forecast, 2015-2024

Table 4.1 Leading Eight Smoking Cessation Markets, 2007-2008

Table 4.2 Smoking Cessation Country Markets Forecasts, 2009-2014

Table 4.3 Smoking Cessation Country Markets Forecasts, 2015-2024

Table 4.4 US Smoking Cessation Market Sales, 2007-2008

Table 4.5 Leading US Smoking Cessation Product Types, 2007-2008

Table 4.6 US Smoking Cessation Product Type Sales Forecast, 2009-2014

Table 4.7 US Smoking Cessation Product Type Sales Forecast, 2015-2024

Table 4.8 Leading Canadian Smoking Cessation Product Types, 2007

Table 4.9 Leading UK Smoking Cessation Product Types, 2007

Table 4.10 Leading French Smoking Cessation Product Types, 2007

Table 4.11 Leading Swedish Smoking Cessation Product Types, 2007

Table 4.12 Leading German Smoking Cessation Product Types, 2007

Table 4.13 Leading Australian Smoking Cessation Product Types, 2007

Table 5.1 BRIC Smoking Cessation Markets, 2007 & 2024

Table 6.1 SWOT Chart for the Smoking Cessation Market

Table 6.2 Smoking Prevalence and Smoking Cessation Revenue Per Smoker in Twenty
Countries with Highest Number of Smokers

Table 7.1 Key Smoking Cessation Pipeline Products

Table 8.1 Smoking Cessation Country Markets 2008 Sales and CAGR, 2008-2024

List of Figures

Figure 3.1 Leading Smoking Cessation Product Types, 2007

Figure 3.2 Leading Smoking Cessation Brands, 2007

Figure 3.3 Leading Manufacturers of Smoking Cessation Products, 2007

Figure 3.4 Global Smoking Cessation Market Forecast, 2009-2024

Figure 3.5 Smoking Cessation Product Type Sales Forecast, 2009-2024

Figure 3.6 Smoking Cessation Product Type Sales & Market Share, 2007, 2014, 2019
and 2024

Figure 3.7 Nicotine Replacement Therapies Sales Forecast, 2009-2024

Figure 3.8 Chantix/Champix Sales Forecast, 2009-2024

Figure 4.1 2007 Smoking Cessation Market Share by Country

Figure 4.2 2014 Smoking Cessation Market Share by Country

Figure 4.3 2019 Smoking Cessation Market Share by Country

Figure 4.4 2024 Smoking Cessation Market Share by Country

Figure 4.5 Leading US Smoking Cessation Product Types, 2007

Figure 4.6 US Smoking Cessation Market Forecast, 2009-2024

Figure 4.7 US Nicotine Replacement Therapies Sales Forecast, 2009-2024

Figure 4.8 Chantix (US) Sales Forecast, 2009-2024

Figure 4.9 Canadian Smoking Cessation Market Forecast, 2009-2024

Figure 4.10 UK Smoking Cessation Market Forecast, 2009-2024

Figure 4.11 French Smoking Cessation Market Forecast, 2009-2024

Figure 4.12 Swedish Smoking Cessation Market Forecast, 2009-2024

Figure 4.13 German Smoking Cessation Market Forecast, 2009-2024

Figure 4.14 Australian Smoking Cessation Market Forecast, 2009-2024

Figure 4.15 Japanese Smoking Cessation Market Forecast, 2009-2024

Figure 5.1 BRIC Smoking Cessation Markets CAGR, 2008-2024

Figure 5.2 Brazilian Smoking Cessation Market Forecast, 2009-2024

Figure 5.3 Russian Smoking Cessation Market Forecast, 2009-2024

Figure 5.4 Indian Smoking Cessation Market Forecast, 2009-2024

Figure 5.5 Chinese Smoking Cessation Market Forecast, 2009-2024

Figure 6.1 Twenty Countries with Highest Number of Tobacco Smokers

Figure 8.1 Global Smoking Cessation Market Forecast, 2009-2024

To order this report:

Smoking Cessation Report, 2009-2024

http://www.reportlinker.com/p0109863/Smoking-Cessation-Report-2009-2024.html

More market research reports here!

Reportlinker
Nicolas: nbo@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626

Copyright Business Wire 2009